A recent meta-analysis suggests that treating some of the psychological complications of multiple sclerosis may have a positive effect on physical symptoms as well
Cynthia McKelvey
Multiple sclerosis is a disease that eats away not only at a person’s physical capabilities, but also...
People with MS often feel anxious about MRIs and frequently lack basic knowledge of this diagnostic procedure. Is an education program that creates “expert patients” the answer?
Laurie Barclay, M.D.
Persons with multiple sclerosis often feel stressed while in the magnetic resonance imaging scanner and then...
Researchers presented a new mouse model for fatigue at the 2014 Society for Neuroscience meeting. The model is the first of its kind and works by manipulating the pro-inflammatory cytokine interleukin-1β.
Cynthia McKelvey
There’s a new animal model coming down the pike that may be of use to...
In the face of suggestive but inconclusive studies, Emily Willingham explains why she chooses to take 5,000 IU of vitamin D daily and vows to stop declining her mother’s offer of cod liver oil
Emily Willingham, Ph.D.
The answer is easy for me: When I first started having symptoms, no one tested my...
Researchers at the University of California, San Francisco, have developed a new tool that allows clinicians to track an individual’s disease course over time and compare it to a core data set of other MS patients. The tool is currently in beta-testing at UCSF.
Cynthia McKelvey
Pierre-Antoine Gourraud, Ph.D., of the University of California, San Francisco, and I huddled around his iPad and...
A large case-control study showed no causal link between current vaccines and the risk of MS or other CNS demyelinating disease, but there was a short-term increased risk in younger patients
Laurie Barclay, M.D.
A large nested case-control study, published October 20 in JAMA Neurology, showed no...
The risk of relapse is higher in the postpartum period, but there are conflicting suggestions for women with MS about reducing this risk. Can exclusive breastfeeding alone prevent relapses? How soon after delivery should DMTs be reintroduced? Are any DMTs safe to take while breastfeeding?
Griselda Zuccarino-Catania, Ph.D.
For any parent, the first few months after delivery are tumultuous—adapting to a new...
RPC1063, an experimental oral immunomodulator, is looking promising as it progresses through clinical testing. At the ACTRIMS-ECTRIMS meeting in September, Amit Bar-Or presented results of the phase 2 trial suggesting the drug is as effective as and safer than its counterpart, fingolimod.
Cynthia McKelvey
RPC1063 may open the door to more convenient treatment options for relapsing-remitting MS, if...